The Giacomantonio Immuno-Oncology Research Group

Dr. Carman Giacomantonio is a surgeon and surgical oncologist at the QEII Health Sciences Center and a professor of surgery at Dalhousie University. He is also the Chief of Surgical Services at CEHHA in Truro, NS. Dr. Giacomantonio’s research interests include cancer metastases, specifically breast, melanoma, and colorectal cancer. He has conducted several studies on the impact of surgical procedures on the tumor microenvironment and subsequent development of cancer metastases, as well as ways to mitigate this risk through targeted therapies.
Dr. Giacomantonio has published several notable papers, including “Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model” and “Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A”. He has also contributed to guidelines on the use of cytoreductive surgery and HIPEC in patients with peritoneal surface malignancy.
Dr. Giacomantonio serves on several advisory boards, including the Medical Advisory Board for Colorectal Cancer Canada.
Overall, Dr. Carman Giacomantonio is a highly accomplished surgeon and researcher with a focus on cancer metastases and targeted therapies. His contributions to the field have been significant, and he continues to serve on advisory boards and conduct research to improve cancer treatment and outcomes.
Dr. Carman Giacomantonio is serving as PI for Sona’s study. The study aims to evaluate the ability of the therapy to act as a catalyst to generate immune responses and provide data that will form part of any future regulatory submissions in support of the development of its Targeted Hyperthermia Therapy. The study is innovative and marks the beginning of Sona delivering on the ‘mountain of data’ they committed to developing in support of their planned regulatory submissions for human clinical trial approvals. The results of the study are anticipated to provide valuable insights into the development of Targeted Hyperthermia Therapy, a photothermal cancer therapy that uses therapeutic heat to treat solid cancer tumors. The use of nanotechnology in cancer therapy is a rapidly growing field, and the study is an exciting development in the search for more effective and targeted cancer treatments.